With which drugs is Apelvis taken?

Apelix, as an innovative targeted drug, is mainly used to treat advanced or metastatic breast cancer that is hormone receptor positive, human epidermal growth factor receptor2 negative, and carries PIK3CA gene mutations. The emergence of this drug provides new treatment opportunities for patients who do not respond well to traditional treatments.

In the treatment of breast cancer, Apelvis is often used in combination with other drugs to enhance the therapeutic effect and reduce side effects. Among them, the combination with fulvestrant is particularly common. Fulvestrant is an estrogen receptor antagonist that can reduce the stimulating effect of estrogen on tumor cells. When used in combination with fulvestrant, Apelvis can more comprehensively inhibit the growth and spread of breast cancer cells, thereby extending the progression-free survival of patients. Studies have shown that the combination of apelvis and fulvestrant significantly reduces patients' risk of disease progression or death and improves overall response rates compared with fulvestrant alone.

In addition, Apelvis may be used in combination with steroid hormones such as dexamethasone. Dexamethasone can reduce some of the side effects caused by apelvis, such as rash and hyperglycemia, thereby improving patient tolerance and quality of life. At the same time, immune checkpoint inhibitors such as pembrolizumab can also be used in combination with apelvis. This combination therapy can activate the patient's own immune system and further enhance the anti-tumor effect.

In addition to the above-mentioned drugs, Apelvis can also be used in combination with other chemotherapy drugs or targeted drugs according to the patient's specific conditions and the doctor's recommendations. These combined treatment options aim to control the disease more effectively and prolong the survival time of patients through the synergistic effect of multiple drugs.

Overall, Apelvis shows good potential and application prospects in the treatment of breast cancer. Through combined use with a variety of drugs, it can provide patients with more personalized and comprehensive treatment plans, helping patients better cope with the disease, improve treatment effects and quality of life.